The situations Biomavens is engaged to solve.

Growth Plateau Despite Strong Capability

The product, platform, or service is real and the team is good. Revenue is meaningful — and the growth curve has flattened. New HLS buyers are slow; existing ones aren't expanding.

• —Ideal healthcare buyer re-prioritization
• —Narrative and positioning realignment
• —GTM sequencing for the next phase
• —Commercial operating cadence

Capability-to-Market Translation

The organization has strong platforms, services, AI capabilities, or data assets — but HLS buyers don't understand what problem they solve, why it matters now, or how to buy them.

• —Ideal buyer, buyer pain, and value-driver clarity
• —Offer architecture and sales narrative
• —Activation path and proof-point logic
• —Decision-ready commercial materials

Platform-to-Value Disconnect

A technology or services company has strong delivery — but the conversation with enterprise HLS buyers stays anchored on features and implementation instead of business value.

• —Buyer decision map and executive narrative
• —Use-case prioritization and QBR structure
• —Strategic account plans
• —Workflow-level value framing

Strategic Accounts Not Expanding

Key HLS accounts often stall when the provider is viewed as a vendor, implementer, or staff-augmentation partner rather than a business advisor — and expansion conversations get stuck below the executive line.

• —Account reframe around executive priorities
• —Workflow and outcome mapping
• —Roadmap alignment and expansion thesis
• —QBR narrative and executive engagement model

Services-Firm Growth Architecture

Professional services, agency, consulting, training, analytics, and technology-services firms often grow through relationships and strong delivery, but struggle to turn client trust into repeatable expansion.

• —Commercial operating model connecting BD, consultants, and account leads
• —Consultant buying-signal framework and handoff process
• —Strategic account planning and expansion cadence
• —Sales activation and growth playbook

Founder-Led Growth That Isn't Scaling

The founder still carries the relationships, the sales judgment, and the executive conversation. The next layer of the commercial team can't yet run the motion without them.

• —Repeatable sales motion and qualification
• —Account and pipeline operating cadence
• —Coaching at executive-conversation level
• —Commercial leadership model for the next phase

Enterprise Healthcare Sales Friction

Pipeline activity exists but progression doesn't. Procurement, clinical, IT, and finance all weigh in. Deals stall at the same stages — and the playbook only really lives in one or two reps' heads.

• —Value narrative and discovery design
• —Sales playbook and qualification
• —Pipeline cadence and forecast discipline
• —Coaching at executive-conversation level

Unclear ICP in Healthcare

The team is selling to everyone who will take a meeting. Win rates are noisy, segments are blurred, and the field can't tell a great-fit account from a wrong-fit one in time to matter.

• —Segment and ICP definition with evidence
• —Account scoring and prioritization
• —Messaging by segment and buyer role
• —Field qualification standards

U.S. Healthcare Expansion for Global Firms

Global healthcare & life sciences, AI, analytics, or services companies often have strong capability but limited U.S. commercial traction — and need a focused, credible path to build it.

• —U.S. ideal buyer and buyer narrative
• —Offer architecture and target-account strategy
• —Sales motion design and pipeline cadence
• —First-stage commercial operating model

Executive Strategic Advisory

Leadership is making consequential calls in motion — repositioning, expansion, fundraise, or transformation — and needs senior judgment in the room that isn't carrying internal history.

• —Independent read on the situation
• —Portfolio and prioritization framing
• —Positioning refinement
• —Standing executive cadence